The dual inhibition of microtubule dynamics and immune checkpoint signaling represents a promising strategy in cancer therapy by simultaneously disrupting cell proliferation and immune evasion. Both αβ-tubulin and dimeric PD-L1...
Galaz-Araya et al. (Thu,) studied this question.